October 03, 2014
Global Green Announces Expiration of Merial Agreement
TALLAHASSEE, Fla. – October 3, 2014 – Global Green, Inc. (GOGC: Pink Sheets), a green bio-pharmaceutical company, today announced that on October 1, 2014, the agreement with Merial Ltd. to conduct an internal evaluation of the Salmogenics vaccine technology expired.
About Global Green, Inc.
Global Green, Inc. is a green bio-pharmaceutical company committed to identifying technology platforms and commercializing vaccines that contain natural organisms that are not genetically modified, utilizing pharmaceutical standards without the use of mercury. For more information, visitwww.globalgreeninc.com.
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties which include, among others, the inherent uncertainties associated with smaller reporting companies including, without limitation, other risks detailed from time to time in the Company’s periodic reports filed with the SEC.